Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 14, 2012

Horizon Strikes X-Man Deal with ATCC

  • Horizon Discovery granted biological resources provider American Type Culture Collection (ATCC) a license to distribute a select set of its X-Man™ isogenic cell lines to academic and nonprofit customers as a part or in conjuction with ATCC’s own Tumor Cell Panels, for noncommercial research applications. The agreement, wihich excludes Japan, also doesn’t cover distribution of the X-Man cell lines in isolation.

    “Horizon’s X-Man cell line panels are a great complement for ATCC Tumor Cell Panels and will be a valuable resource for our customers,” comments Raymond Cypess, Ph.D., ATCC CEO. “The ability to work with accurate disease model cell lines is of great benefit, particularly in oncology research where many mutations studied are rare, and reliable sources of patient-derived cell lines are scarce.” 



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »